Premium
Soluble β‐glucan from Grifola frondosa induces tumor regression in synergy with TLR9 agonist via dendritic cell‐mediated immunity
Author(s) -
Masuda Yuki,
Nawa Daiki,
Nakayama Yoshiaki,
Konishi Morichika,
Nanba Hiroaki
Publication year - 2015
Publication title -
journal of leukocyte biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.819
H-Index - 191
eISSN - 1938-3673
pISSN - 0741-5400
DOI - 10.1189/jlb.1a0814-415rr
Subject(s) - dendritic cell , biology , cytotoxic t cell , t cell , priming (agriculture) , interleukin 12 , cd40 , immunology , immune system , microbiology and biotechnology , biochemistry , in vitro , botany , germination
Cancer therapy using a TLR9 agonist and β‐glucan from Grifola frondosa synergistically induced dendritic cell maturation, inducing a Th1‐type response and tumor regression.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom